Barinthus Biotherapeutics plc (BRNS)
NASDAQ: BRNS · Real-Time Price · USD
0.895
-0.085 (-8.70%)
Nov 22, 2024, 4:00 PM EST - Market closed

Barinthus Biotherapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Market Capitalization
3614288388--
Market Cap Growth
-60.62%62.36%-77.38%---
Enterprise Value
-57-5-104162--
Last Close Price
0.893.692.3511.11--
PE Ratio
--16.41---
PS Ratio
2.33177.441.961445.93--
PB Ratio
0.220.760.361.53--
P/TBV Ratio
0.380.950.431.86--
EV/Sales Ratio
---605.57--
Debt / Equity Ratio
0.080.070.040.03-14.730.15
Asset Turnover
0.070.000.160.000.14-
Quick Ratio
8.4311.9116.8719.816.122.67
Current Ratio
8.9312.4517.4020.326.272.83
Return on Equity (ROE)
-32.60%-34.15%2.15%-40.99%-420.05%-
Return on Assets (ROA)
-18.65%-20.73%-0.65%-15.55%-30.07%-
Return on Capital (ROIC)
-20.52%-22.24%-0.70%-17.00%-36.98%-
Earnings Yield
-160.66%-51.54%6.09%-13.13%--
FCF Yield
-172.51%-39.59%-23.47%-8.70%--
Buyback Yield / Dilution
-2.31%-0.57%-47.40%-227.59%-33580.72%-
Total Shareholder Return
-2.31%-0.57%-47.40%-227.59%-33580.72%-
Source: S&P Capital IQ. Standard template. Financial Sources.